NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 3.60% |
DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.65% |
ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 2.44% |
ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 2.18% |
PHAT | Phathom Pharmaceuticals Inc | Healthcare | Biotechnology | 2.18% |
MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 2.17% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.08% |
TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 2.07% |
LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.04% |
AUP | Aurinia Pharmaceuticals Inc | Technology | Technical & System Software | 1.96% |
BGNE | BeiGene Ltd | Healthcare | Biotechnology | 1.90% |
BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 1.90% |
EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.89% |
IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 1.88% |
RARE | Ultragenyx | Healthcare | Biotechnology | 1.85% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 1.84% |
UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.80% |
YMAB | Y mAbs Therapeutics | Healthcare | Biotechnology | 1.79% |
TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 1.77% |